83-5980-93 Erythropoietin (EPO, MVCD2, EP, Epoetin) 100ug 052029

※お見積書はカートで印刷できます

冷凍

特徴

  • Erythropoietin (EPO) is a 34kD glycoprotein hormone in the type I cytokine family and is related to thrombopoietin.
  • Its three N-glycosylation sites, four alpha helices, and N- to C-terminal disulfide bond are conserved across species.
  • Glycosylation of EPO is required for biological activities in vivo.
  • Mature human EPO shares 75%-84% amino acid sequence identity with bovine, canine, equine, feline, mouse, sheep, porcine, and rat EPO.
  • EPO is primarily produced in the kidney by a population of fibroblast-like cortical interstitial cells adjacent to the proximal tubules.
  • It is also produced in much lower, but functionally significant amounts by fetal hepatocytes and in adult liver and brain.
  • EPO promotes erythrocyte formation by preventing the apoptosis of early erythroid precursors which express the EPO receptor (EPO R).
  • EPO R has also been described in brain, retina, heart, skeletal muscle, kidney, endothelial cells, and a variety of tumor cells.
  • Ligand induced dimerization of EPO R triggers JAK2-mediated signaling pathways followed by receptor/ligand endocytosis and degradation.
  • Rapid regulation of circulating EPO allows tight control of erythrocyte production and hemoglobin concentrations.
  • Anemia or other causes of low tissue oxygen tension induce EPO production by stabilizing the hypoxia-induceable transcription factors HIF-1 alpha and HIF-2 alpha.
  • EPO additionally plays a tissue-protective role in ischemia by blocking apoptosis and inducing angiogenesis.
  • Applications:Suitable for use in Neutralization.
  • Other applications not tested.
  • Recommended Dilution:Neutralization: Measured by its ability to neutralize Erythropoietin induced proliferation in the TF‑1 human erythroleukemic cell line.
  • The Neutralization Dose (ND50 ) is typically 0.02-0.2ug/ml in the presence of 0.3units/ml recombinant human ErythropoietinOptimal dilutions to be determined by the researcher.
  • Storage and Stability:Lyophilized and reconstituted products are stable for 12 months after receipt at -20℃.
  • Reconstitute with sterile PBS.
  • Aliquot to avoid repeated freezing and thawing.
  • Store at -20℃.
  • For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
  • Further dilutions can be made in assay buffer.

仕様

  • Size:100ug
  • 抗体種類:Mab
  • 宿主:mouse
  • Source Antibody:human
  • Grade:Affinity Purified
  • Purity:Purified by Protein G affinity chromatography from hybridoma culture supernatant. Endotoxin: ≤0.1EU/ug (LAL).
  • Form:Supplied as a lyophilized powder from PBS, pH 7.4, 5% trehalose. Reconstitute with 200ul sterile PBS.
  • Specificity:Recognizes human Erythropoietin/EPO
  • Clone # USB:24G4
  • Isotype:IgG1
  • Calc Applications Abbrev:N
  • Calc Crossreactivity:Hu
  • Immunogen:Recombinant protein corresponding to Ala28-Arg193 from human Erythropoietin, expressed in CHO cells
  • EU Commodity Code:30021010
  • この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
  • 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
  • 【試薬に関するお問合せ】
  • アズワン株式会社 試薬・プロセス材料グループ
  • TEL:06-6447-8641
  • FAX:06-6447-8642
  • E-mail:[email protected]
アズワン品番
83-5980-93
型番
052029
入り数
1個
標準価格
185,000円(税抜)
WEB価格
アズワン在庫 [?]
数量

※お気に入り機能はログイン後にご利用いただけます

よくあるご質問

よくあるご質問(FAQ)

掲載カタログ情報

掲載カタログ名 掲載ページ

次の商品を登録しました。

商品計:

お買い物を続ける カートを見る